Here, we demonstrate that CRISPR plasmids activate the same type of antiviral response through STING and identify cytidine deaminase APOBEC3G as a key regulator in limiting CRISPR transfection in KCs (Figure 2, B and C). The gene discussed is APOBEC3G; the disease is dry eye syndrome.